Latest News


October 6, 2021

A selective antibiotic for Lyme disease

Nadja Leimer, Xiaoqian Wu, Yu Imai, Linden T. Hu, Helen I. Zgurskaya, Kim Lewis

October 1, 2020

A Distinct Microbiome Signature in Posttreatment Lyme Disease Patients

Madeleine Morrissette, Norman Pitt, Antonio González, Philip Strandwitz, Mariaelena Caboni, Alison W. Rebman, Rob Knight, Anthony D’Onofrio, John N. Aucott, Mark J. Soloski, Kim Lewis

March 2, 2020

Azlocillin can be the potential drug candidate against drug-tolerant Borrelia burgdorferi sensu stricto JLB31

Venkata Raveendra Pothineni, Hari-Hara S. K. Potula, Aditya Ambati, Venkata Vamsee Aditya Mallajosyula, Brindha Sridharan, Mohammed Inayathullah, Mohamed Sohail Ahmed, and Jayakumar Rajadas

December 16, 2019

Chronic Lyme Disease: An Evidence-Based Definition by the ILADS Working Group

By Samuel Shor, Christine Green, Beatrice Szantyr, Steven Philips, Kenneth Liegner, Joseph Burrascano Jr., Robert Bransfield, Elizabeth L. Maloney

November 16, 2009

Ineffectiveness of tigecycline against persistent Borrelia burgdorferi

By Barthold SW, Hodzic E, Imai DM, Feng S, Yang X, Luft BJ


Gillibrand Requests Federal Money to Fight Tick-Borne Illnesses


Elucidating Host-microbe Interactions to Address Vector-borne Diseases


Do you live near the lone-star tick? Map shows where most alpha-gal cases occur


UT Researchers Study the Mysterious Interplay between Ticks, Viruses, and Immunity


Tick-Killing Fungus Research Underway at N.S. University


A Lyme vaccine is in late-stage trials. Could an anti-tick vaccine be next?